AstraZeneca Presents Imfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting

World News: . []

CAMBRIDGE United Kingdom, April 16 2018 GLOBE NEWSWIRE -- AstraZeneca and MedImmune its global biologics research and development arm today presented efficacy and safety data from two Phase I trials evaluating durvalumab in combination wit h treme...

More news and information about AstraZeneca

Published By:

Globe Newswire: 22:05 GMT Monday 16th April 2018

Published: .

Search for other references to "astrazeneca" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us